Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs/miR-1205/lncRNA SRD5A3-AS1) panel in NASH animal model

Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis

(2020) Atsuko Takai et al.   BMC GASTROENTEROLOGY

NAFLD 2020: The State of the Disease

(2020) Thomas G. Cotter et al.   GASTROENTEROLOGY

Natural history of NASH and HCC

(2020) Francesco Negro   LIVER INTERNATIONAL

Probiotic Bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease

(2020) Yan Yan et al.   AMB Express

Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers

(2020) Olfa Khalifa et al.   DISEASE MARKERS

Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway

(2019) Zijian Zhao et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma

(2019) Zhimin Ye et al.   World Journal of Surgical Oncology

Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease

(2019) Sang Bong Ahn et al.   Scientific Reports

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention

(2018) Umberto Vespasiani-Gentilucci et al.   Archives of Medical Science

Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?

(2018) Valerio Nobili et al.   Archives of Medical Science

Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis

(2018) Ming Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Pathogenesis of non-alcoholic fatty liver disease mediated by YAP

(2018) Ping Chen et al.   Hepatology International

Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism

(2018) Amin Ardestani et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The role of the microbiome in NAFLD and NASH

(2018) Aleksandra A Kolodziejczyk et al.   EMBO Molecular Medicine

Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis

(2017) Sachin H. Patel et al.   GASTROENTEROLOGY

Therapies in non-alcoholic steatohepatitis (NASH)

(2017) Abdul M. Oseini et al.   LIVER INTERNATIONAL

Gut microbiota–derived short-chain fatty acids and kidney diseases

(2017) Lingzhi Li et al.   Drug Design Development and Therapy

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy

(2017) Junli Ma et al.   Nutrients

Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver

(2017) Claudia C. Alves et al.   Frontiers in Microbiology

Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ

(2016) Jing Yi et al.   HEPATOLOGY

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

(2016) Juan P. Arab et al.   HEPATOLOGY

The role of the gut microbiota in NAFLD

(2016) Christopher Leung et al.   Nature Reviews Gastroenterology & Hepatology

Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models

(2016) Bernd Schnabl et al.   NUCLEAR MEDICINE AND BIOLOGY

miRNAs in non-alcoholic fatty liver disease

(2016) Zhen He et al.   Frontiers of Medicine

Yes-associated protein in the liver: Regulation of hepatic development, repair, cell fate determination and tumorigenesis

(2015) Quy Nguyen et al.   DIGESTIVE AND LIVER DISEASE

Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease

(2015) Mariana Verdelho Machado et al.   JOURNAL OF HEPATOLOGY

DIANA-miRPath v3.0: deciphering microRNA function with experimental support

(2015) Ioannis S. Vlachos et al.   NUCLEIC ACIDS RESEARCH

MicroRNAs in Nonalcoholic Fatty Liver Disease

(2015) György Baffy   Journal of Clinical Medicine

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

(2014) Tannaz Eslamparast et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model

(2011) Ren-ying Xu et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance

(2011) Jill A. Parnell et al.   LIVER INTERNATIONAL

The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

(2010) Nailing Zhang et al.   DEVELOPMENTAL CELL

Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver

(2010) S. Benhamouche et al.   GENES & DEVELOPMENT

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats

(2009) Craig D. Fisher et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Probiotics Reduce the Inflammatory Response Induced by a High-Fat Diet in the Liver of Young Rats

(2009) Emanuela Esposito et al.   JOURNAL OF NUTRITION